BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30627930)

  • 1. Design and Development of Lidocaine Microemulsions for Transdermal Delivery.
    Wang Y; Wang X; Wang X; Song Y; Wang X; Hao J
    AAPS PharmSciTech; 2019 Jan; 20(2):63. PubMed ID: 30627930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linker-based lecithin microemulsions for transdermal delivery of lidocaine.
    Yuan JS; Ansari M; Samaan M; Acosta EJ
    Int J Pharm; 2008 Feb; 349(1-2):130-43. PubMed ID: 17904775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained delivery of prilocaine and lidocaine using depot microemulsion system:
    Zhang X; Dang M; Zhang W; Lei Y; Zhou W
    Drug Dev Ind Pharm; 2020 Feb; 46(2):264-271. PubMed ID: 32000536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant.
    Sarheed O; Dibi M; Ramesh KVRNS; Drechsler M
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering.
    Shukla A; Krause A; Neubert RH
    J Pharm Pharmacol; 2003 Jun; 55(6):741-8. PubMed ID: 12841933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.
    Zhang L; Wang J; Chi H; Wang S
    Drug Deliv; 2016 Nov; 23(9):3529-3537. PubMed ID: 27340888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of eucalyptol microemulsions for topic delivery of curcumin.
    Liu CH; Chang FY
    Chem Pharm Bull (Tokyo); 2011; 59(2):172-8. PubMed ID: 21297295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo.
    Sintov AC; Shapiro L
    J Control Release; 2004 Mar; 95(2):173-83. PubMed ID: 14980766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.
    Yuan JS; Yip A; Nguyen N; Chu J; Wen XY; Acosta EJ
    Int J Pharm; 2010 Jun; 392(1-2):274-84. PubMed ID: 20363304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
    Zhao X; Sun Y; Li Z
    Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedical applications of microemulsion through dermal and transdermal route.
    Shukla T; Upmanyu N; Agrawal M; Saraf S; Saraf S; Alexander A
    Biomed Pharmacother; 2018 Dec; 108():1477-1494. PubMed ID: 30372850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of lidocaine nanoemulsion and its transdermal absorption by rat skin ex vivo].
    Zhu XL; Li GF; Zeng K; Cheng ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):451-4. PubMed ID: 20335107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of transdermal delivery of artemisinin using microemulsion vehicle based on ionic liquid and lidocaine ibuprofen.
    Zhang Y; Cao Y; Meng X; Li C; Wang H; Zhang S
    Colloids Surf B Biointerfaces; 2020 May; 189():110886. PubMed ID: 32109824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of Non-aqueous Microemulsions to Improve the Delivery of Lipophilic Drugs to the Skin.
    Carvalho VF; de Lemos DP; Vieira CS; Migotto A; Lopes LB
    AAPS PharmSciTech; 2017 Jul; 18(5):1739-1749. PubMed ID: 27757922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended release of lidocaine from linker-based lecithin microemulsions.
    Yuan JS; Acosta EJ
    Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chemical enhancers in the transdermal delivery of lidocaine.
    Lee PJ; Ahmad N; Langer R; Mitragotri S; Prasad Shastri V
    Int J Pharm; 2006 Feb; 308(1-2):33-9. PubMed ID: 16321488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants.
    Liu CH; Chang FY; Hung DK
    Colloids Surf B Biointerfaces; 2011 Jan; 82(1):63-70. PubMed ID: 20828994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.